Found: 56
Select item for more details and to access through your institution.
A Novel Kindred with Familial Gastrointestinal Stromal Tumors Caused by a Rare KIT Germline Mutation (N655K): Clinico-Pathological Presentation and TKI Sensitivity.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 4, p. 234, doi. 10.3390/jpm10040234
- By:
- Publication type:
- Article
Association of HLA-G 3′UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 12, p. 2737, doi. 10.3390/pharmaceutics14122737
- By:
- Publication type:
- Article
Impact of ABCG2 and ABCB1 Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3303, doi. 10.3390/ijms24043303
- By:
- Publication type:
- Article
Characterizing Metastatic HER2-Positive Gastric Cancer at the CDH1 Haplotype.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 47, doi. 10.3390/ijms19010047
- By:
- Publication type:
- Article
HLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1366, doi. 10.3390/ijms18071366
- By:
- Publication type:
- Article
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 9, p. 1482, doi. 10.3390/ijms17091482
- By:
- Publication type:
- Article
Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin.
- Published in:
- Metabolites (2218-1989), 2023, v. 13, n. 10, p. 1035, doi. 10.3390/metabo13101035
- By:
- Publication type:
- Article
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2023, v. 31, n. 2, p. 267, doi. 10.1007/s40199-023-00465-z
- By:
- Publication type:
- Article
Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2016, v. 23, n. 13, p. 4302, doi. 10.1245/s10434-016-5451-5
- By:
- Publication type:
- Article
Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2011, v. 18, n. 13, p. 3686, doi. 10.1245/s10434-011-1822-0
- By:
- Publication type:
- Article
Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 3, p. 510, doi. 10.1007/s10147-012-0410-z
- By:
- Publication type:
- Article
HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0144000
- By:
- Publication type:
- Article
Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0084940
- By:
- Publication type:
- Article
Clonal Selection of a Novel Deleterious TP53 Somatic Mutation Discovered in ctDNA of a KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumor Resistant to Imatinib.
- Published in:
- Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00036
- By:
- Publication type:
- Article
CYP2D6 and CYP2C8 pharmacogenetics and pharmacological interactions to predict imatinib plasmatic exposure in GIST patients.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1089, doi. 10.1111/bcp.15551
- By:
- Publication type:
- Article
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.
- Published in:
- Cancers, 2023, v. 15, n. 20, p. 5036, doi. 10.3390/cancers15205036
- By:
- Publication type:
- Article
The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 175, doi. 10.3390/cancers15010175
- By:
- Publication type:
- Article
The Riddle of Cetuximab-Related Skin Toxicity: 1 H-NMR Sebum Analysis Revealed Dynamic Lipid Alterations Associated with Skin Toxicity Development in Metastatic Colorectal Cancer Patients.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5308, doi. 10.3390/cancers14215308
- By:
- Publication type:
- Article
Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1502, doi. 10.3390/cancers14061502
- By:
- Publication type:
- Article
Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 14, p. 3504, doi. 10.3390/cancers13143504
- By:
- Publication type:
- Article
IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1705, doi. 10.3390/cancers13071705
- By:
- Publication type:
- Article
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.
- Published in:
- Cancers, 2021, v. 13, n. 5, p. 1053, doi. 10.3390/cancers13051053
- By:
- Publication type:
- Article
Integration of Serum Metabolomics into Clinical Assessment to Improve Outcome Prediction of Metastatic Soft Tissue Sarcoma Patients Treated with Trabectedin.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1983, doi. 10.3390/cancers12071983
- By:
- Publication type:
- Article
Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer.
- Published in:
- Cancers, 2019, v. 11, n. 6, p. 880, doi. 10.3390/cancers11060880
- By:
- Publication type:
- Article
Exocrine and Endocrine Modulation in Common Gastric Carcinoma.
- Published in:
- American Journal of Clinical Pathology, 2012, v. 137, n. 5, p. 712, doi. 10.1309/AJCPM13KVNCZQBUV
- By:
- Publication type:
- Article
UGT1A polymorphisms as genetic biomarkers for hepatocellular carcinoma risk in Caucasian population.
- Published in:
- Liver International, 2017, v. 37, n. 9, p. 1345, doi. 10.1111/liv.13411
- By:
- Publication type:
- Article
Improved outcome with multimodal treatment and imatinib rechallenge in advanced GIST.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2341522, doi. 10.1001/jamanetworkopen.2023.41522
- By:
- Publication type:
- Article
Germline variability and tumor expression level of ribosomal protein gene RPL28 are associated with survival of metastatic colorectal cancer patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49477-3
- By:
- Publication type:
- Article
Feasibility and Oncological Outcome of Preoperative Chemoradiation With IMRT Dose Intensification for Locally Advanced Esophageal and Gastroesophageal Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.626275
- By:
- Publication type:
- Article
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0225225
- By:
- Publication type:
- Article
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Trabectedin may be a valuable treatment option for elderly patients with metastatic soft tissue sarcomas.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1437732
- By:
- Publication type:
- Article
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
- Published in:
- British Journal of Cancer, 2018, v. 119, n. 5, p. 565, doi. 10.1038/s41416-018-0190-y
- By:
- Publication type:
- Article
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Author Correction: The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical‐Biomolecular Markers Significantly Associated With Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 3, p. 686, doi. 10.1002/cpt.2511
- By:
- Publication type:
- Article
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 4, p. 994, doi. 10.1002/cpt.1257
- By:
- Publication type:
- Article
A Clinical-Genetic Score to Identify Surgically Resected Colorectal Cancer Patients Benefiting From an Adjuvant Fluoropyrimidine-Based Therapy.
- Published in:
- Frontiers in Pharmacology, 2018, p. N.PAG, doi. 10.3389/fphar.2018.01101
- By:
- Publication type:
- Article
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00367
- By:
- Publication type:
- Article
Clinical validity of a DPYD-based pharmacogenetic test to predict severe toxicity to fluoropyrimidines.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 12, p. 2971, doi. 10.1002/ijc.29654
- By:
- Publication type:
- Article
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 9, p. 888, doi. 10.3390/diagnostics14090888
- By:
- Publication type:
- Article
Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1212634
- By:
- Publication type:
- Article
Improved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00712
- By:
- Publication type:
- Article
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
- Published in:
- Oncology Research, 2020, v. 28, n. 9, p. 847, doi. 10.3727/096504021X16232280278813
- By:
- Publication type:
- Article
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical Exercise.
- Published in:
- Oncologist, 2022, v. 27, n. 2, p. e158, doi. 10.1093/oncolo/oyab035
- By:
- Publication type:
- Article